Parallel Advisors, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,017
-44.8%
1,144
-39.1%
0.00%
-100.0%
Q2 2023$19,971
+12.7%
1,877
+11.4%
0.00%0.0%
Q1 2023$17,726
+36.6%
1,685
+60.9%
0.00%0.0%
Q4 2022$12,972
+44.1%
1,047
+15.2%
0.00%
Q3 2022$9,000
+12.5%
909
+23.5%
0.00%
Q2 2022$8,000
+700.0%
736
+1147.5%
0.00%
Q1 2022$1,00059
+168.2%
0.00%
Q3 2021$0
-100.0%
22
-79.6%
0.00%
Q2 2019$1,0001080.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders